Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × gallium maltolate × 1 year × Clear all

Status

Not yet recruiting 2 No longer available 1 Active not recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Interventions

Suspensions 2 Powders 2 zanidatamab 1 trametinib 1 talquetamab 1 taletrectinib 1 sotorasib 1 ruxolitinib 1 revumenib 1 patritumab deruxtecan 1 omburtamab I-131 1 omaveloxolone 1 leronlimab 1 gallium maltolate 1 dabrafenib 1 ceritinib 1 capmatinib 1 asparaginase erwinia chrysanthemi recombinant 1 apalutamide 1 Standard of Care 1 Paclitaxel 1 Nivolumab 1 HMPL-013 1 Everolimus 1 Docetaxel 1 Asparaginase 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06404034 2026-03-04

Expanded Access to Gallium Maltolate (GaM)

Imaging Biometrics, LLC

No longer available

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡